The FDA announced the approval of darolutamide for treating metastatic castration-sensitive prostate cancer. This review was conducted under Project Orbis, which allows for concurrent submission and review...
A presentation at the Practical Updates in Primary Care 2025 virtual conference explored three cases, challenging primary care providers to rethink common infectious disease diagnoses while emphasizing the...
Researchers set out to determine whether short-course vaginal cuff brachytherapy regimen maintains quality of life and acceptable toxicity in patients with early-stage endometrial cancer.
An ultra-low-dose 0.005% estriol vaginal gel reduced recurrent urinary tract infections in postmenopausal women with genitourinary syndrome of menopause, offering a safe and effective alternative to...
A team of researchers compared the presence of short-term side effects using two image-guided radiation treatment—magnetic resonance imaging-guided daily adaptive prostate stereotactic body radiotherapy...
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive...
The Women's Preventive Services Initiative, a national coalition of women’s health professional organizations and patient representatives, has released new guidelines recommending universal screening...
